are they banning compounded semaglutide 📢 FDA has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the Compounded Semaglutide Prescription - In

For some individuals, the dose may need to be adjusted based on how well they respond to the medication and how comfortable they feel with the side effects

Omdat Retatrutide nog niet officieel is goedgekeurd voor commercieel gebruik, kan de zuiverheid en samenstelling sterk variren per leverancier

Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not use this medication

A 2025 analysis found that GLP-1 agonists given for diabetes were associated with a reduced risk of substance use among hundreds of thousands of United States Veterans and a 2024 examination of over 500k patients 4 Qeadan, F., McCunn, A., & Tingey, B